200 related articles for article (PubMed ID: 28117940)
1. Peripheral Blood Gene Expression Changes Associated With Primary Graft Dysfunction After Lung Transplantation.
Diamond JM; Cantu E; Porteous MK; Suzuki Y; Meyer KC; Lederer DJ; Milewski RK; Arcasoy S; D'Ovidio F; Bacchetta M; Sonett JR; Singh G; Costa J; Tobias JW; Rodriguez H; Van Deerlin VM; Olthoff KM; Shaked A; Chang BL; Christie JD;
Am J Transplant; 2017 Jul; 17(7):1770-1777. PubMed ID: 28117940
[TBL] [Abstract][Full Text] [Related]
2. Adipose Gene Expression Profile Changes With Lung Allograft Reperfusion.
Diamond JM; Arcasoy S; McDonnough JA; Sonett JR; Bacchetta M; D'Ovidio F; Cantu E; Bermudez CA; McBurnie A; Rushefski M; Kalman LH; Oyster M; D'Errico C; Suzuki Y; Giles JT; Ferrante A; Lippel M; Singh G; Lederer DJ; Christie JD;
Am J Transplant; 2017 Jan; 17(1):239-245. PubMed ID: 27421969
[TBL] [Abstract][Full Text] [Related]
3. Protein Quantitative Trait Loci Analysis Identifies Genetic Variation in the Innate Immune Regulator TOLLIP in Post-Lung Transplant Primary Graft Dysfunction Risk.
Cantu E; Suzuki Y; Diamond JM; Ellis J; Tiwari J; Beduhn B; Nellen JR; Shah R; Meyer NJ; Lederer DJ; Kawut SM; Palmer SM; Snyder LD; Hartwig MG; Lama VN; Bhorade S; Crespo M; Demissie E; Wille K; Orens J; Shah PD; Weinacker A; Weill D; Wilkes D; Roe D; Ware LB; Wang F; Feng R; Christie JD;
Am J Transplant; 2016 Mar; 16(3):833-40. PubMed ID: 26663441
[TBL] [Abstract][Full Text] [Related]
4. Use of donor-derived-cell-free DNA as a marker of early allograft injury in primary graft dysfunction (PGD) to predict the risk of chronic lung allograft dysfunction (CLAD).
Keller M; Bush E; Diamond JM; Shah P; Matthew J; Brown AW; Sun J; Timofte I; Kong H; Tunc I; Luikart H; Iacono A; Nathan SD; Khush KK; Orens J; Jang M; Agbor-Enoh S
J Heart Lung Transplant; 2021 Jun; 40(6):488-493. PubMed ID: 33814284
[TBL] [Abstract][Full Text] [Related]
5. Lung Innate Lymphoid Cell Composition Is Altered in Primary Graft Dysfunction.
Monticelli LA; Diamond JM; Saenz SA; Tait Wojno ED; Porteous MK; Cantu E; Artis D; Christie JD
Am J Respir Crit Care Med; 2020 Jan; 201(1):63-72. PubMed ID: 31394048
[No Abstract] [Full Text] [Related]
6. The Lung Allograft Microbiome Associates with Pepsin, Inflammation, and Primary Graft Dysfunction.
McGinniss JE; Whiteside SA; Deek RA; Simon-Soro A; Graham-Wooten J; Oyster M; Brown MD; Cantu E; Diamond JM; Li H; Christie JD; Bushman FD; Collman RG
Am J Respir Crit Care Med; 2022 Dec; 206(12):1508-1521. PubMed ID: 36103583
[No Abstract] [Full Text] [Related]
7. Preoperative plasma club (clara) cell secretory protein levels are associated with primary graft dysfunction after lung transplantation.
Shah RJ; Wickersham N; Lederer DJ; Palmer SM; Cantu E; Diamond JM; Kawut SM; Lama VN; Bhorade S; Crespo M; Demissie E; Sonett J; Wille K; Orens J; Weinacker A; Shah P; Arcasoy S; Wilkes DS; Christie JD; Ware LB;
Am J Transplant; 2014 Feb; 14(2):446-52. PubMed ID: 24400993
[TBL] [Abstract][Full Text] [Related]
8. The Perioperative Lung Transplant Virome: Torque Teno Viruses Are Elevated in Donor Lungs and Show Divergent Dynamics in Primary Graft Dysfunction.
Abbas AA; Diamond JM; Chehoud C; Chang B; Kotzin JJ; Young JC; Imai I; Haas AR; Cantu E; Lederer DJ; Meyer KC; Milewski RK; Olthoff KM; Shaked A; Christie JD; Bushman FD; Collman RG
Am J Transplant; 2017 May; 17(5):1313-1324. PubMed ID: 27731934
[TBL] [Abstract][Full Text] [Related]
9. Soluble Adhesion Molecules During Ex Vivo Lung Perfusion Are Associated With Posttransplant Primary Graft Dysfunction.
Hashimoto K; Cypel M; Kim H; Machuca TN; Nakajima D; Chen M; Hsin MK; Zamel R; Azad S; Waddell TK; Liu M; Keshavjee S
Am J Transplant; 2017 May; 17(5):1396-1404. PubMed ID: 27977885
[TBL] [Abstract][Full Text] [Related]
10. Local complement activation is associated with primary graft dysfunction after lung transplantation.
Kulkarni HS; Ramphal K; Ma L; Brown M; Oyster M; Speckhart KN; Takahashi T; Byers DE; Porteous MK; Kalman L; Hachem RR; Rushefski M; McPhatter J; Cano M; Kreisel D; Scavuzzo M; Mittler B; Cantu E; Pilely K; Garred P; Christie JD; Atkinson JP; Gelman AE; Diamond JM
JCI Insight; 2020 Sep; 5(17):. PubMed ID: 32750037
[TBL] [Abstract][Full Text] [Related]
11. Endothelial Glycocalyx Shedding Predicts Donor Organ Acceptability and Is Associated With Primary Graft Dysfunction in Lung Transplant Recipients.
Sladden TM; Yerkovich S; Grant M; Zhang F; Liu X; Trotter M; Hopkins P; Linhardt RJ; Chambers DC
Transplantation; 2019 Jun; 103(6):1277-1285. PubMed ID: 30444804
[TBL] [Abstract][Full Text] [Related]
12. The relationship between plasma lipid peroxidation products and primary graft dysfunction after lung transplantation is modified by donor smoking and reperfusion hyperoxia.
Diamond JM; Porteous MK; Roberts LJ; Wickersham N; Rushefski M; Kawut SM; Shah RJ; Cantu E; Lederer DJ; Chatterjee S; Lama VN; Bhorade S; Crespo M; McDyer J; Wille K; Orens J; Weinacker A; Arcasoy S; Shah PD; Wilkes DS; Hage C; Palmer SM; Snyder L; Calfee CS; Ware LB; Christie JD;
J Heart Lung Transplant; 2016 Apr; 35(4):500-507. PubMed ID: 26856667
[TBL] [Abstract][Full Text] [Related]
13. Elevated plasma clara cell secretory protein concentration is associated with high-grade primary graft dysfunction.
Diamond JM; Kawut SM; Lederer DJ; Ahya VN; Kohl B; Sonett J; Palmer SM; Crespo M; Wille K; Lama VN; Shah PD; Orens J; Bhorade S; Weinacker A; Demissie E; Bellamy S; Christie JD; Ware LB;
Am J Transplant; 2011 Mar; 11(3):561-7. PubMed ID: 21299834
[TBL] [Abstract][Full Text] [Related]
14. The Role of TGF-β in the Association Between Primary Graft Dysfunction and Bronchiolitis Obliterans Syndrome.
DerHovanessian A; Weigt SS; Palchevskiy V; Shino MY; Sayah DM; Gregson AL; Noble PW; Palmer SM; Fishbein MC; Kubak BM; Ardehali A; Ross DJ; Saggar R; Lynch JP; Elashoff RM; Belperio JA
Am J Transplant; 2016 Feb; 16(2):640-9. PubMed ID: 26461171
[TBL] [Abstract][Full Text] [Related]
15. Plasma protein biomarkers for primary graft dysfunction after lung transplantation: a single-center cohort analysis.
Chacon-Alberty L; Kanchi RS; Ye S; Hochman-Mendez C; Daoud D; Coarfa C; Li M; Grimm SL; Baz M; Rosas I; Loor G
Sci Rep; 2022 Sep; 12(1):16137. PubMed ID: 36167867
[TBL] [Abstract][Full Text] [Related]
16. Graft dysfunction immediately after reperfusion predicts short-term outcomes in living-donor lobar lung transplantation but not in cadaveric lung transplantation.
Mizota T; Miyao M; Yamada T; Sato M; Aoyama A; Chen F; Date H; Fukuda K
Interact Cardiovasc Thorac Surg; 2016 Mar; 22(3):314-20. PubMed ID: 26705301
[TBL] [Abstract][Full Text] [Related]
17. Plasma monocyte chemotactic protein-1 levels at 24 hours are a biomarker of primary graft dysfunction after lung transplantation.
Shah RJ; Diamond JM; Lederer DJ; Arcasoy SM; Cantu EM; Demissie EJ; Kawut SM; Kohl B; Lee JC; Sonett J; Christie JD; Ware LB
Transl Res; 2012 Dec; 160(6):435-42. PubMed ID: 22989614
[TBL] [Abstract][Full Text] [Related]
18. Elevated plasma angiopoietin-2 levels and primary graft dysfunction after lung transplantation.
Diamond JM; Porteous MK; Cantu E; Meyer NJ; Shah RJ; Lederer DJ; Kawut SM; Lee J; Bellamy SL; Palmer SM; Lama VN; Bhorade SM; Crespo M; Demissie E; Wille K; Orens J; Shah PD; Weinacker A; Weill D; Arcasoy S; Wilkes DS; Ware LB; Christie JD;
PLoS One; 2012; 7(12):e51932. PubMed ID: 23284823
[TBL] [Abstract][Full Text] [Related]
19. A panel of lung injury biomarkers enhances the definition of primary graft dysfunction (PGD) after lung transplantation.
Shah RJ; Bellamy SL; Localio AR; Wickersham N; Diamond JM; Weinacker A; Lama VN; Bhorade S; Belperio JA; Crespo M; Demissie E; Kawut SM; Wille KM; Lederer DJ; Lee JC; Palmer SM; Orens J; Reynolds J; Shah A; Wilkes DS; Ware LB; Christie JD
J Heart Lung Transplant; 2012 Sep; 31(9):942-9. PubMed ID: 22694851
[TBL] [Abstract][Full Text] [Related]
20. Role of innate immunity in primary graft dysfunction after lung transplantation.
Diamond JM; Wigfield CH
Curr Opin Organ Transplant; 2013 Oct; 18(5):518-23. PubMed ID: 23995372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
